Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2025-12-24 @ 10:37 PM
NCT ID: NCT03547635
Eligibility Criteria: Inclusion Criteria: 1. Have participated in the informed consent process and signed a study-specific informed consent document. 2. Be able and willing to comply with study procedures, including study visits, study dressing regimens, and compliance with study required offloading device. 3. Be ≥ 21 years of age. 4. Have Type I or Type II diabetes mellitus with Investigator-confirmed glycosylated hemoglobin (HbA1c) of ≤ 12%. 5. Have at least one diabetic foot ulcer Ulcer size (i.e., area) is \> 1 cm2 and \< 12 cm2. 6. Have adequate vascular perfusion of the affected limb Exclusion Criteria: 1. The subject was previously randomized and treated under this clinical study protocol. 2. The study ulcer has features that necessitates surgical operating-room debridement and/or penetrates to capsule/tendon/bone. 3. The subject is unable to safely ambulate with the use of a study required offloading boot. 4. The subject has suspected or confirmed gangrene or wound infection of the study ulcer. 5. The subject has suspected or confirmed osteomyelitis. 6. In the opinion of the Investigator, the subject has received or is scheduled to receive during study participation, a medication or treatment which is known to interfere with or affect the rate and quality of wound healing 7. The subject has a history of bone cancer or metastatic disease of the affected limb, radiation therapy to the foot, or has had chemotherapy prior to signing the Informed Consent Form for trial participation. 8. The subject is currently pregnant or is actively trying to conceive. 9. In the opinion of the Investigator, the subject is unable to comply with the treatment regimen 10. In the opinion of the Investigator, the subject has a history of, or is currently diagnosed with, any illness or condition, other than diabetes, that could interfere with wound healing. 11. In the opinion of the Investigator, the subject has a condition that could inhibit wound healing. 12. The subject has ulcers secondary to a disease other than diabetes.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 21 Years
Study: NCT03547635
Study Brief:
Protocol Section: NCT03547635